Team

Multidisciplinary Division

Lucy Eddowes

Lucy Eddowes

Head of the Multidisciplinary Division

Position: Head of the Multidisciplinary Division
Tel: +44 (0) 1223 913 030
Email: lucy.eddowes@costellomedical.com

Lucy has managed a wide variety of projects since joining Costello Medical, including HTA submissions, systematic literature reviews and value dossiers, in a broad range of disease areas. In her role as Head of the Multidisciplinary Division, Lucy is particularly excited about continuing to diversify and improve the service offerings at Costello Medical, ensuring that they continue to meet the high expectations of both clients and colleagues. Lucy also manages Costello Medical’s pro bono project activities, and coordinates the company’s expanding interest in public health through collaboration with public sector and charitable organisations. She really enjoys the variety of work and opportunities on offer at Costello Medical; Lucy is part of the recruitment team and has performed research for presentation at ISPOR alongside her client responsibilities.

Prior to joining Costello Medical, Lucy graduated from the University of Oxford in 2006 with an upper second class Masters degree in Chemistry. She then completed her DPhil studies in Clinical Medicine in 2010 and continued her research at the Weatherall Institute of Molecular Medicine in Oxford as a post-doctoral researcher. Lucy’s doctoral and post-doctoral research covered a variety of infectious diseases, focusing on the role of the essential nutrient iron, as well as global health issues such as anaemia and vaccines.

Annabel Griffiths

Annabel Griffiths

Consultant — Rare Diseases Lead

Position: Consultant — Rare Diseases Lead
Tel: +44 (0) 1223 913 025
Email: annabel.griffiths@costellomedical.com

As the Rare Diseases Lead at Costello Medical, Annabel leads a range of project types across our different service offerings, and has a specialist interest in orphan and ultra-orphan indications.

Annabel has experience in a wide-range of rare diseases, including paediatric conditions and genetic disorders, where she has led teams to successfully provide high-quality project support at various stages of clinical development. Annabel is passionate about the societal value of treatments for rare diseases and is dedicated to the delivery of pro bono support to a number of rare disease charities, including our long-term collaboration with the rare disease charity Findacure. Annabel plays an active role in academic discussions in this area, leading an issue panel at the 2016 European ISPOR conference focussed on off-label treatments in rare diseases. Annabel was also a panellist at DPharm Europe 2016, discussing Costello Medical’s ongoing collaborative work developing economic models focused on drug repurposing in rare diseases.

Prior to joining Costello Medical in April 2015, Annabel completed a PhD in Cell and Developmental Biology at the University of Cambridge, having previously received an upper second class BA in Natural Sciences at the same institution. During her PhD, Annabel used a combination of imaging, genetics and computer modelling to examine the role and relationship of four intracellular proteins that mediate the link between cells and the surrounding extracellular matrix. Following her PhD, Annabel volunteered with a non-governmental organisation in Cambodia, cementing her enthusiasm for the healthcare sector and charity work.

Rebecca Beale

Rebecca Beale

Consultant

Position: Consultant
Tel: +44 (0) 1223 913 033
Email: rebecca.beale@costellomedical.com

As a cross-divisional Consultant, Rebecca enjoys the opportunity to work on a variety of project types, ranging from HTA submissions to medical affairs support, value dossiers, literature reviews and economic models. Through these projects she has gained experience in a number of disease areas, including epilepsy, oncology and the spondyloarthropathies. She is also involved in several internal initiatives, including recruitment, the organisation of induction training for new starters, and keeping the Costello Medical LinkedIn pages up-to-date.

During her time at Costello Medical, Rebecca has conducted several pieces of original research, one of which she was delighted to present at the 17th Annual European ISPOR Congress as an oral presentation. To pursue her interest in health economics further, in 2015 Rebecca completed the Postgraduate Certificate in Health Economics for Health Care Professionals (by distance learning) at the University of York.

Rebecca originally graduated from the University of Cambridge in June 2013 with an upper second class degree in Natural Sciences, specialising in Neuroscience.

Catherine Bunting

Catherine Bunting

Consultant

Position: Consultant
Tel: +44 (0) 1223 913 063
Email: catherine.bunting@costellomedical.com

As a Consultant in the Multidisciplinary Division, Catherine has experience in the management of a wide range of project types including value materials, congress support and HTA submissions, across a broad range of indications. Catherine particularly enjoys the scientific variety of her role, and is excited to continue to grow her skills and knowledge through the projects that she works on, as well as maintaining the excellent quality standards at Costello Medical. In addition to her client responsibilities, Catherine takes responsibility for organising internal training activities, to ensure that the wealth of expertise within Costello Medical is shared throughout the company.

Before joining Costello Medical, Catherine graduated from the University of Cambridge with an upper second class honours degree in Biological Natural Sciences, specialising in Pathology, and in 2016 she completed the Postgraduate Certificate in Health Economics for Health Care Professionals at the University of York.

Henrike Resemann

Henrike Resemann

Senior Analyst

Position: Senior Analyst
Tel: +44 (0) 1223 792 476
Email: henrike.resemann@costellomedical.com

Henrike completed her doctorate in Pathology at the University of Cambridge in early 2016. During her PhD, she studied a non-conventional cell death mechanism during post-lactational regression of the mammary gland. Prior to her doctoral training, Henrike received a BSc in Biochemistry & Cell Biology and an MSc in Biomedical Sciences. During her 9 years in academia, she worked on a wide range of disease areas, including breast cancer, thyroid cancer and chronic Graft-versus-Host-Disease. Henrike has published multiple scientific papers, including a review on oncogene Stat3 in cancer and cell death. She has also presented her findings at numerous national and international conferences and symposia.

Henrike joined the company in January 2016 and is excited about contributing to the diverse projects at Costello Medical. She is particularly looking forward to applying her background in oncology and immunology, and expanding her knowledge of other disease areas.

Bryony Langford

Bryony Langford

Senior Analyst

Position: Senior Analyst
Tel: +44 (0) 1223 913 079
Email: bryony.langford@costellomedical.com

Bryony graduated from University College London with a first class honours degree in Natural Sciences, specialising in Neuroscience, Mathematics and Statistics. As an undergraduate she completed a summer internship at the John Innes Centre working on calcium flux detection in legumes. Through this internship Bryony developed a keen interest in biological modelling using her favourite programming language, R.

She then went on to complete a Masters degree in Computational Biology from the University of Cambridge. For her Masters thesis Bryony completed a joint project with AstraZeneca and Cancer Research UK. This project explored integrative clustering of genomic, mutation and copy number data as a way of determining novel non-small cell lung cancer subtypes which may have differing drug responses. After graduating Bryony worked as a financial analyst at the London Ambulance Service where she developed her knowledge of the public sector.

Bryony joined Costello Medical in February 2016. She is excited to develop her statistical and programming skills further whilst working on a wide variety of projects, and is looking forward to contributing to the growth and development of the company.

Kate Hanman

Kate Hanman

Senior Analyst

Position: Senior Analyst
Tel: +44 (0) 1223 792 479
Email: kate.hanman@costellomedical.com

Kate graduated from the University of East Anglia in July 2014 with an upper second class degree in Biochemistry. For her final year research project she investigated the roles DNases play in preventing the re-establishment of Campylobacter biofilm populations. The results generated from this project went on to be published in two peer-reviewed scientific journals. Following her undergraduate degree, Kate completed a Masters degree in Epidemiology at Imperial College London in 2015.

Motivated to work within the healthcare industry and improve the lives of patients, Kate joined Costello Medical as a Scientific Intern and was delighted to transition into the permanent role of Analyst in March 2016. Since joining Costello Medical, Kate has worked on a diverse range of projects across several disease areas in the Evidence Development and HTA and Health Economics Divisions. She has particularly enjoyed becoming involved with the company’s pro bono projects, which have focused on benefiting patients who suffer from rare diseases in the UK. Kate looks forward to working within the talented and dynamic team at Costello Medical as well as further developing and applying her scientific knowledge across a variety of projects.

Chris McDonald

Chris McDonald

Senior Analyst

Position: Senior Analyst
Tel: +44 (0) 1223 792 535
Email: chris.mcdonald@costellomedical.com

Chris graduated from the University of York in 2011 with a first class Masters degree in Chemistry, before going on to Imperial College London where he embarked on a PhD in Membrane Biophysics. His research utilised a multidisciplinary approach to investigate the effector function of membrane stress response systems involved in bacterial pathogenicity and multi-drug resistance. The results obtained from the project were published in two peer-reviewed scientific journals and delivered at a number of national and international conferences. After completing his doctorate, Chris undertook a year-long post-doctoral position working on the development of a novel class of drug molecules in collaboration with GlaxoSmithKline.

Driven by a keen interest in the healthcare industry and a desire to apply his scientific knowledge in a more commercial environment, Chris joined Costello Medical as a Cross-Divisional Analyst in September 2016. He is looking forward to working on a variety of projects across Costello Medical’s different service areas and broadening his knowledge of the healthcare sector.

Benjamin Fell

Benjamin Fell

Analyst

Position: Analyst
Tel: +44 (0) 1223 792 548
Email: benjamin.fell@costellomedical.com

Before joining Costello Medical, Ben completed his PhD in Molecular Cell Biology at Queen Mary University London in 2016. During his postgraduate studies, he worked on the in vitro-modelling of rare skin diseases and the assessment of nanopolymer-based systems for transdermal drug delivery, with parts of his work having been published in peer-reviewed journal articles. Previous to this, he received a Masters degree in Molecular Biotechnology from the University of Lübeck (Germany) while investigating the use of adult human stem cells in neural tissue engineering.

Interested in applying his knowledge of translational biosciences in a more commercial and varied setting, Ben joined Costello Medical in January 2017 as a Scientific Intern. He quickly developed a passion for the work in healthcare consulting and gladly accepted the opportunity to transition to a permanent position in May 2017. As a Cross-Divisional Analyst he particularly enjoys being able to contribute to a wide range of projects and to continuously learn about new aspects of Evidence Development and Health Technology Assessment.

Megan Besford

Megan Besford

Biostatistician

Position: Biostatistician
Tel: +44 (0) 1223 792 495
Email: megan.besford@costellomedical.com

Megan graduated from the University of Sheffield in 2014 with a first class honours degree in Mathematics. Continuing her studies at the University of Sheffield, Megan was awarded with a studentship from the National Institute of Health Research and achieved a distinction in her MSc in Statistics with Medical Applications in 2015.

After completing her Masters degree, Megan joined a consultancy as a Statistician where she was responsible for the provision of statistical and programming support to the pharmaceutical industry. Megan worked across different phases of clinical trials and managed a team which provided statistical analysis for an observational study. Through her academic and commercial background, Megan has experience in using a wide range of programming languages, particularly SAS and R.

Megan joined Costello Medical Consulting in April 2017. She is excited to apply her statistical expertise and clinical background to a wide variety of projects and is looking forward to further developing her knowledge in different therapeutic areas.

Pippa Macnair

Pippa Macnair

Analyst

Position: Analyst
Tel: +44 (0) 1223 913 020
Email: pippa.macnair@costellomedical.com

Pippa graduated from the University of St Andrews with a first class Honours degree in Geography in 2016, before going on to complete a Masters in Public Health at the London School of Hygiene and Tropical Medicine. Her research projects to date have focused on geographical variations in health outcomes, with her undergraduate dissertation focusing on obesity in Scotland, and her postgraduate thesis exploring short-term mortality from colon cancer.

She looks forward to applying the knowledge and experience gained through her studies in a more commercial environment, and working on a wide range of projects as part of the Multidisciplinary Division. She is particularly keen to further her interest in non-communicable disease, and to work across the different divisions to gain an appreciation of the drug development process.